Topoisomerase IIa gene amplification predicts favorable outcome of tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2 positive breast cancer. Results from the randomized trial SBG 9401

    Activity: Talk or presentation › Conference presentation

    Description

    Contributors: Kellokumpu-Lehtinen Pirkko / Tieteelliset esitykset
    Period13 May 2005
    Event titleASCO 41st Annual Meeting
    Event typeOther
    Degree of RecognitionInternational